Vaccination against human papillomavirus in childhood: the next rubella analogue?

Area of Science:

• Public Health
• Vaccinology
• Epidemiology

Background:

• Current human papillomavirus (HPV) vaccination programs primarily target girls.
• The rubella vaccination program included both genders to protect women of childbearing age.
• Direct comparisons of vaccination strategies can identify new targets and solutions for health interventions.

Purpose of the Study:

• To evaluate the potential benefits of including boys in the HPV vaccination program.
• To explore how a gender-inclusive HPV vaccination strategy could enhance disease elimination.
• To assess the impact of cost-effective HPV vaccines on broader implementation.

Main Methods:

• Comparative analysis of vaccination program structures (rubella vs. HPV).
• Modeling potential transmission dynamics of high-risk HPV types.
• Review of economic factors influencing vaccine accessibility.

Main Results:

• Including both sexes in HPV vaccination can interrupt high-risk HPV transmission between males and females.
• A gender-inclusive approach ensures comprehensive protection for women of childbearing age.
• Reduced costs of new-generation HPV vaccines may facilitate male and female vaccination.

Conclusions:

• Expanding HPV vaccination to include boys is a viable strategy to enhance disease control.
• A parallel to the rubella vaccination model offers a framework for effective HPV elimination.
• The inclusion of males in HPV vaccination programs is crucial for maximizing public health benefits.